Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinomaLi-fen Deng(Sun Yat-sen University), Yanhong Wang(Fudan University)BMC CancerJuly 29, 201310.1186/1471-2407-13-363Cited by 21SaveCiteExport RISWatch citationsRelated PapersPhosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudy|BMC Medicine|2009|147Silencing of IL13RA2 promotes partial epithelial‐mesenchymal transition in hepatocellular carcinoma via ERK signaling pathway activation|FEBS Open Bio|2019|6